AbstractClass I phosphoinositide 3‐kinases (PI3K) are known to play a significant role in neutrophil chemotaxis. However, the relative contributions of different PI3K isoforms, and how these impact on lung inflammation, have not been addressed. In vitro studies using wild‐type and PI3Kγ knockout neutrophils demonstrated the major role of the γ isoform in chemotactic but not chemokinetic events. This was confirmed by a model of direct chemokine instillation into the airways in vivo. Within all studies, a low yet significant degree of neutrophil movement in the absence of PI3Kγ could be observed. No role for the δ isoform was demonstrated both in vitro and in vivo using PI3Kδ kinase‐dead knock‐in mice. Moreover, further studies using the broad‐spectrum PI3K inhibitors wortmannin or LY294002 showed no other class I PI3K isoforms to be involved in these chemotactic processes. Here, we identify a contributory PI3K‐independent mechanism of neutrophil movement, yet demonstrate PI3Kγ as the pivotal mediator through which the majority of neutrophils migrate into the lung in response to chemokines. These data resolve the complexities of chemokine‐induced neutrophilia and PI3K signaling and define the γ isoform as a promising target for new therapeutics to treat airway inflammatory diseases.